ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Internal Medicine

Top Internal Medicine Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SCOTT STEVENS MD

Internal Medicine

280

$136K

54
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$485
Average prescription price

Avg: $62

KASHIF MEMON MD

Internal Medicine

916

$307K

30
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 23%

$335
Average prescription price

Avg: $62

JAMES CHAMBERLAIN MD

Internal Medicine

1,694

$290K

172
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 23%

$171
Average prescription price

Avg: $62

ROBERT DAY MD

Internal Medicine

2,063

$347K

271
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 23%

$168
Average prescription price

Avg: $62

CARL KABLITZ MD

Internal Medicine

925

$153K

62
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 23%

$166
Average prescription price

Avg: $62

GARY ALEXANDER MD

Internal Medicine

1,984

$329K

195
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 23%

$166
Average prescription price

Avg: $62

DAVID SHASKEY M.D.

Internal Medicine

1,341

$212K

160
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$158
Average prescription price

Avg: $62

JOHN MCCORMICK M.D.

Internal Medicine

1,846

$290K

319
224 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$157
Average prescription price

Avg: $62

JAHAN IMANI MD

Internal Medicine

1,479

$211K

152
48 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$143
Average prescription price

Avg: $62

STEVEN CALL M.D.

Internal Medicine

4,099

$402K

288
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$98
Average prescription price

Avg: $62

VON WELCH MD

Internal Medicine

9,460

$910K

442
402 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 23%

$96
Average prescription price

Avg: $62

JEFFREY HOLVERSON MD

Internal Medicine

1,840

$176K

50
11 are 65+

78%
patients receiving schedule two controlled substances

Avg: 5%

38%
patients receiving schedule three controlled substances

Avg: 11%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 23%

$96
Average prescription price

Avg: $62

EDWARD REDD MD

Internal Medicine

3,311

$317K

96
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$96
Average prescription price

Avg: $62

RICHARD BENNETT MD

Internal Medicine

10,632

$1.01M

632
560 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 23%

$95
Average prescription price

Avg: $62

MARTIN HOLLINGSWORTH MD

Internal Medicine

2,144

$204K

89
65 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$95
Average prescription price

Avg: $62

PHILIP ROBERTS MD

Internal Medicine

10,628

$994K

701
649 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 23%

$94
Average prescription price

Avg: $62

ELENA GONCHAROVA MD

Internal Medicine

2,106

$195K

98
78 are 65+

26%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 23%

$92
Average prescription price

Avg: $62

REGINA DRUEDING M.D.

Internal Medicine

1,365

$126K

80
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 23%

$92
Average prescription price

Avg: $62

PENNY PEACOCK M.D.

Internal Medicine

1,186

$109K

64
48 are 65+

23%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$92
Average prescription price

Avg: $62

PAUL PILGRAM M.D.

Internal Medicine

2,642

$240K

95
64 are 65+

29%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$91
Average prescription price

Avg: $62

STACY JOHNSON M.D.

Internal Medicine

404

$36K

181
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 23%

$89
Average prescription price

Avg: $62

BARBARA RIZZARDI MD

Internal Medicine

5,719

$495K

250
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 23%

$87
Average prescription price

Avg: $62

LUCINDA BATEMAN MD

Internal Medicine

2,099

$175K

103
32 are 65+

43%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$83
Average prescription price

Avg: $62

PATRICE HIRNING M.D.

Internal Medicine

2,791

$229K

156
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$82
Average prescription price

Avg: $62

JEFFREY OGDEN M.D

Internal Medicine

6,465

$529K

322
265 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$82
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank